T-CAFE: Impact of Expired Carbon Monoxide Measurement on Smoking Cessation of Pregnant Women

Sponsor
University Hospital, Limoges (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03842449
Collaborator
(none)
102
1
3
36
2.8

Study Details

Study Description

Brief Summary

France is the country of Europe where the prevalence of pregnant women smokers is the highest (35.9% before pregnancy and in the 3rd quarter 21.8% in 2008).

In the investigator's country, among the smokers of early pregnancy with the usual care, only 30% manage to stop during pregnancy.

Maternal smoking during pregnancy is a clearly identified risk factor for the course of pregnancy and the unborn child.

The measurement of carbon monoxide (CO) expired in pregnancy monitoring consultation is part of the recommendations of the consensus conference "Pregnancy and Tobacco" (ANAES, October 2004) and the parliamentary report on smoking by JL Touraine and D. Jacquat (Feb 2012). However, this recommendation has not entered the current practice. The research aims to justify the clinical relevance of this recommendation by demonstrating the positive impact of expired CO measurement on the rate of discontinuation during pregnancy.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: BabyCO
  • Other: Biological samples
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
102 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Impact of Expired Carbon Monoxide Measurement on Smoking Cessation of Pregnant Women - Tobacco Pregnancy Addictive Pregnant Women
Actual Study Start Date :
Mar 18, 2019
Anticipated Primary Completion Date :
Mar 18, 2022
Anticipated Study Completion Date :
Mar 18, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Smoking pregnant woman withCO measurement

Diagnostic Test: BabyCO
An expired CO measurement will be performed by BabyCO and the result will be returned to the smoking pregnant woman by the consultant.

Other: Biological samples
The nature of the samples taken during the delivery are: maternal blood, cord blood placenta fragment

Other: Smoking pregnant woman without CO measurement

Other: Biological samples
The nature of the samples taken during the delivery are: maternal blood, cord blood placenta fragment

Other: Non Smoking pregnant woman

Other: Biological samples
The nature of the samples taken during the delivery are: maternal blood, cord blood placenta fragment

Outcome Measures

Primary Outcome Measures

  1. Smoking cessation on the date of birth [Date of birth]

    Evaluate the impact on maternal smoking cessation rate at birth of a strategy combining maternal expired CO measurement, restitution, and outcome comment initiated no later than at the 24th week of amenorrhea and conducted thoughout the whole pregnancy.

Secondary Outcome Measures

  1. Impact on maternal, placental and fetal exposure to the toxic and compounds of tobacco smoke. [Date of birth]

    Impact on maternal, placental and fetal exposure to the toxic and compounds of tobacco smoke measured in maternal, cordal blood and placenta by ICP-MS, GC-MS and LC-MS methods

  2. Impact on the intention of breastfeeding on the date of birth [Date of birth]

    Impact on the intention of breastfeeding on the date of birth evaluated by a questionnaire

  3. Predictive value of expired CO in relation to maternal-fetal exposure to these toxic and compounds [Date of birth]

    Determine the predictive value of expired CO in relation to maternal-fetal exposure to these toxic and compounds

  4. Maternal expired CO on the day of birth [Date of birth]

    Maternal expired CO on the day of birth

  5. Determinants of smoking cessation on the day of birth [Date of birth]

    Potential determinants of smoking cessation, including: age, parity, precariousness assessed by the EPICES score, history of smoking before pregnancy, expired CO measurement, etc.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria :
Group of smoking pregnant women (N = 600):
  • Pregnant women declaring themselves smokers (at least one cigarette a day).

  • Aged at least 18 years old.

  • Consultant at Limoges University Hospital before the 24th week of amenorrhea.

  • Desiring to be followed for their entire pregnancy at the Children's.

  • Desiring to give birth at the Children's.

  • Accepting to participate in the study

Group of strictly non-smoking pregnant women (N = 50):
  • Pregnant women :

  • Declaring not to be a smoker (to have been totally weaned for more than one year and to have smoked less than 100 cigarettes in her lifetime) before the beginning of the current pregnancy, and

  • Whose partner and family do not smoke, and

  • Not significantly exposed to tobacco (in their professional environment in particular), and

  • With a CO measurement expired <3 ppm.

  • Aged at least 18 years old.

  • Consultant at Limoges University Hospital before the 24th SA.

  • Desiring to be followed for all their pregnancy and give birth at the Children's Hospital of Limoges.

  • Accepting to participate in the study.

Exclusion Criteria :
Group of smoking pregnant women (N = 600) :
  • Women with the following social and / or legal criteria: guardianship, curatorship, safeguard of justice.

  • Women unable to understand the objectives of the study and the constraints of the protocol.

Group of strictly non-smoking pregnant women (N = 50) :
  • Women with the following social and / or legal criteria: guardianship, curatorship, safeguard of justice.

  • Women unable to understand the objectives of the study and the constraints of the protocol.

  • Women with high blood pressure

  • Diabetic woman

  • Woman with hypothyroidism

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital, Limoges Limoges France 87042

Sponsors and Collaborators

  • University Hospital, Limoges

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Limoges
ClinicalTrials.gov Identifier:
NCT03842449
Other Study ID Numbers:
  • 87RC17_0069 (T-CAFE)
First Posted:
Feb 15, 2019
Last Update Posted:
Mar 17, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Limoges
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 17, 2021